Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Unknown × PD-1 × Clear all

Phase

Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 61 Breast Neoplasms 57 Neoplasms 52 Leukemia, Myeloid, Acute 52 Multiple Myeloma 44 Lymphoma 43 Stomach Neoplasms 40 Colorectal Neoplasms 40 Carcinoma, Hepatocellular 39 Recurrence 38 Neoplasm Metastasis 37 Pancreatic Neoplasms 36 Melanoma 33 Prostatic Neoplasms 31 Leukemia 29 Ovarian Neoplasms 24 Lymphoma, Non-Hodgkin 23 Lung Neoplasms 22 Lymphoma, Large B-Cell, Diffuse 21 Lymphoma, B-Cell 21 Glioblastoma 21 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Hematologic Neoplasms 19 Myelodysplastic Syndromes 18 Leukemia, Lymphocytic, Chronic, B-Cell 18 Esophageal Neoplasms 18 Colonic Neoplasms 18 Lymphoma, Mantle-Cell 17 Sarcoma 15 Carcinoma, Renal Cell 15

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04061928 2019-08-20

Toripalimab With Preoperative Chemoradiotherapy for LA-EGJ

Peking University

Phase 1/2 Unknown

Gastrointestinal

PD-1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡